The risk of early and late CMV DNAemia associated with Campath use in stem cell transplant recipients.

Bone Marrow Transplant · 2010 · PMC4829098 · PMID 19966846

Europe PMC DOI

hedged sentence

0.0024

closest p · 0.0× alpha

0.0024

boldest claim

The sentences

highly significantp = 0.0024actually significant

did not reach statistical significanceno p-value reported

The difference in the cumulative incidence of HCMV DNAemia between the Campath-1H group and the non-Campath group was highly significant (p = 0.0024, Log Rank Score), but the difference between the Campath-1G group and the Campath-1H group did not reach statistical significance.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.